RE:RE:Trading December 29I agree with you that value investors in Algernon are in dire straits if an American stock exchange (NASDAQ) does not rescue this Canadian company.
However, value investors will not be the only losers. Algernon is engaged in research that, if successful, will bring relief from pain and suffering to millions of people around the world.
Algernon's ability to raise capital for research is directly related to its share price. So, if the share is depressed, it will cause unnecessary suffering and is, therefore, a public policy issue. As such, responsible authorities should be examining the issue to determine whether any aspect of the price depression is contrived or artificial and thus should be regulated or proscribed.
But no one seems to looking - not OSFI or IIROC or the CSE or any MP. I know becaudse I have asked them all.